Signal2026-07-30
ClinicalTrials.gov

[PHASE3] Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

Part of

Gastroenterology Clinical Research Trends

Open primary sourceSee the whole picture